- 2024-07-10 08:21TDTM
- 2024-07-10 08:21Anticancer agent 231
- 2024-07-10 08:21Sifuvirtide
- 2024-07-10 08:21WRX606
- 2024-07-10 08:21ARF(26–44), cell-permeable
- 2024-07-10 08:21CTL26
- 2024-07-10 08:21NHSF
- 2024-07-10 08:21Isoorientin-7-O-[6-sinapoyl]-glucoside
- 2024-07-10 08:21NY-ESO-1 (157–165) peptide
- 2024-07-10 08:21HSP70/DnaK substrate peptide
- 2024-07-10 08:20Anticancer agent 221
- 2024-07-10 08:20CYD0682
- 2024-07-10 08:20Cetefloxacin
- 2024-07-10 08:20AcrAP1
- 2024-07-10 08:20Biguanide
- 2024-07-10 08:2010-Deacetylcephalomannine
- 2024-07-10 08:20Apo A-I mimetic 5A peptide
- 2024-07-10 08:20Humanized anti-tac (HAT) binding peptide
- 2024-07-10 08:20BNN6
- 2024-07-10 08:20Insulin solution (human)
